Virus-Induced Tumorigenesis and IFN System

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Oncogenic viruses cause tumors by altering cellular pathways, inhibiting apoptosis, and evading antiviral defenses.
• Type I interferons (IFNs) are crucial cytokines with broad roles beyond antiviral action, including regulating cell proliferation, apoptosis, and immune responses.
• IFNs are vital for host defense against viruses and bacteria, and for immune surveillance against tumors.

Purpose of the Study:

• To review recent research on virus-induced tumorigenesis and the involvement of the interferon (IFN) system.
• To explore how oncogenic viruses interact with cellular antiviral defenses and IFN signaling pathways.
• To highlight the role of microRNAs and extracellular vesicles in virus-induced tumorigenesis and the tumor microenvironment.

Main Methods:

• Review of recent scientific literature on oncogenic viruses and the IFN system.
• Analysis of viral mechanisms for counteracting cellular antiviral defenses.
• Examination of IFN-mediated signaling pathways in the context of virus-induced tumors.

Main Results:

• Oncogenic viruses (e.g., HPV, HBV, Herpesviruses) induce tumors by persistent infection and manipulation of cellular processes.
• Type I IFNs play a critical role in antiviral defense and anti-tumor immunity, but oncogenic viruses can interfere with IFN signaling.
• Emerging mechanisms involving microRNAs and extracellular vesicles contribute to virus-induced tumorigenesis and immune evasion.

Conclusions:

• The interplay between oncogenic viruses, cellular pathways, and the IFN system is complex and critical in tumor development.
• Understanding these interactions offers potential therapeutic targets for preventing and treating virus-associated cancers.
• Further research into viral evasion strategies and IFN modulation is essential for advancing cancer immunotherapy.